One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review

Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil

(2019) Francisco José Dutra Souto et al.   VACCINE

Effectiveness of single‐dose administration of inactivated hepatitis A virus vaccination in the Republic of Korea armed forces, 2013‐2016

(2019) Jae Hyoung Im et al.   JOURNAL OF VIRAL HEPATITIS

Viral Hepatitis and Acute Liver Failure

(2018) Daniel Sedhom et al.   Clinics in Liver Disease

Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention

(2018) Stanley M. Lemon et al.   JOURNAL OF HEPATOLOGY

Hepatitis A vaccine immune response 22 years after vaccination

(2018) Emily Mosites et al.   JOURNAL OF MEDICAL VIROLOGY

Globalization and the Changing Epidemiology of Hepatitis A Virus

(2018) Kathryn H. Jacobsen   Cold Spring Harbor Perspectives in Medicine

Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017

(2018) Huai Wang et al.   Human Vaccines & Immunotherapeutics

Hepatitis A virus strains circulating during 1997-2015 in Campania, a Southern Italy region with periodic outbreaks

(2017) Angela Costantino et al.   JOURNAL OF MEDICAL VIROLOGY

Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers’ Vaccination

(2017) Ravit Bassal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina

(2017) Carlos Espul et al.   Human Vaccines & Immunotherapeutics

Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response

(2016) Orlando Mayorga et al.   JOURNAL OF INFECTIOUS DISEASES

Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina

(2016) Analía Urueña et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12–15 Months of Age

(2016) Ron Dagan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

(2016) Desmond Curran et al.   Human Vaccines & Immunotherapeutics

Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – A systematic review

(2016) Anke L. Stuurman et al.   Human Vaccines & Immunotherapeutics

The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012

(2015) H Levine et al.   Eurosurveillance

Modeling the Long-term Persistence of Hepatitis A Antibody After a Two-Dose Vaccination Schedule in Argentinean Children

(2015) Eduardo L. López et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis

(2015) Dora Estripeaut et al.   VACCINE

Long-term antibody persistence after vaccination with a 2-dose Havrix ™ (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions

(2015) Heidi Theeten et al.   VACCINE

Considerations on the Current Universal Vaccination Policy against Hepatitis A in Greece after Recent Outbreaks

(2015) Kassiani Mellou et al.   PLoS One

Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations

(2013) J.J. Ott et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Evidence of Hepatitis A virus circulation in central Argentina: Seroprevalence and environmental surveillance

(2013) Laura A. Yanez et al.   JOURNAL OF CLINICAL VIROLOGY

Impact of the Single-dose Immunization Strategy Against Hepatitis A in Argentina

(2013) Carla Vizzotti et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children

(2013) Gregory A. Raczniak et al.   VACCINE

Analysis of the circulation of hepatitis A virus in Argentina since vaccine introduction

(2012) M.D. Blanco Fernández et al.   CLINICAL MICROBIOLOGY AND INFECTION

The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988–2007)

(2012) Laura M. Erhart et al.   VACCINE

Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine

(2012) Koen Van Herck et al.   Human Vaccines & Immunotherapeutics

Successful Memory Response following a Booster Dose with a Virosome-Formulated Hepatitis A Vaccine Delayed Up to 11 Years

(2011) Christoph Hatz et al.   Clinical and Vaccine Immunology

Long-Term Immunity After Two Doses of Inactivated Hepatitis A Vaccine, in Argentinean Children

(2010) Eduardo L. López et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children

(2010) Guo-Lin Bian et al.   VACCINE

Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska

(2010) Rosalyn J. Singleton et al.   VACCINE

Declining Hepatitis A Mortality in the United States during the Era of Hepatitis A Vaccination

(2008) Tara M. Vogt et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up

(2008) E. G. Fisenka et al.   JOURNAL OF VIRAL HEPATITIS

Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program

(2008) G. Chodick et al.   JOURNAL OF VIRAL HEPATITIS

Incidence of Hepatitis A in Argentina after vaccination

(2008) M. N. Vacchino   JOURNAL OF VIRAL HEPATITIS